Effects of Macronutrient Excess and composition on oxidative stress: Relevance to diabetes and cardiovascular disease

被引：17

作者：

Ceriello A. ^{[1
]}

机构：

[1] Warwick Medical School, Clinical Sciences Research Institute, University Hospital, Coventry CV2 2DX, Clifford Bridge Road

来源：

Current Atherosclerosis Reports | 2006年 / 8卷 / 6期

关键词：

Insulin Resistance; Insulin Secretion; Impaired Glucose Tolerance; Citric Acid Cycle; Arterioscler Thromb Vasc Biol;

D O I：

10.1007/s11883-006-0022-z

中图分类号：

学科分类号：

摘要：

Type 2 diabetes is a disease that is increasing in prevalence worldwide. In genetically predisposed patients, the combination of excess caloric intake and reduced physical activity induces a state of insulin resistance. When β-cells are not able to compensate for insulin resistance by adequately increasing insulin production, impaired glucose tolerance occurs, which is characterized by excessive postprandial hyperglycemia. Impaired glucose tolerance may evolve into overt diabetes. These three conditions (ie, insulin resistance, impaired glucose tolerance, and overt diabetes) are associated with an increased risk of cardiovascular disease. Intervention trials have demonstrated that diabetes can be prevented by means of lifestyle modifications, antidiabetic drugs directed against insulin resistance or simply postprandial hyperglycemia, and cardiovascular drugs devoid of effects on blood glucose levels. All of these have intracellular antioxidant effects. Evidence on the efficacy of antioxidant interventions is accumulating, and oxidative stress may be a therapeutic target to prevent diabetes as well as cardiovascular complications. Copyright © 2006 by Current Science Inc.

引用

页码：472 / 476

页数：4

共 44 条

[1]

Amos A., McCarthy D., Zimmet P., The rising global burden of diabetes and its complications: Estimates and projections to the year 2010, Diabet Med, 14, SUPPL. 5, (1997)

[2]

Rosembloom A.L., Joe J.R., Young R.S., Winter W.E., Emerging epidemic of type 2 diabetes in youth, Diabetes Care, 22, pp. 345-354, (1999)

[3]

Kannel W.B., McGee D.L., Diabetes and cardiovascular diseases. The Framingham Study, JAMA, 241, pp. 2035-2038, (1979)

[4]

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA, 285, pp. 2486-2497, (2001)

[5]

Hu F.B., Stampfer M.J., Haffner S.M., Et al., Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes, Diabetes Care, 25, pp. 1129-1134, (2002)

[6]

Stern M.P., Diabetes and cardiovascular disease. The "common soil" hypothesis, Diabetes, 44, pp. 369-374, (1995)

[7]

Kahan S.E., The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes, Diabetologia, 46, pp. 3-19, (2003)

[8]

Haffner S.M., Stern M.P., Hazuda H.P., Et al., Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?, JAMA, 263, pp. 2893-2898, (1990)

[9]

Sinha R., Fisch G., Teague B., Et al., Prevalence of impaired glucose tolerance among children and adolescents with marked obesity, N Engl J Med, 346, pp. 802-810, (2002)

[10]

Lakka H.M., Laaksonen D.E., Lakka T.A., Et al., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men, JAMA, 288, pp. 2709-2716, (2002)

← 1 2 3 4 5 →